All 2022 IMRT presentations
View another way?![](//assets.vl.aapm.org/vl/2022/IMRT/0-16347-Moran.jpg)
MO-A-Virtual Acknowledging our Past & Moving IMRT QA Forward: Let's Do This Together
Acknowledging our Past & Moving IMRT QA Forward: Let's Do This TogetherPresented by Jean Moran, PhD
This presentation has an average satisfaction 4.5 (higher is better), with 4 responding
VLID: 16347
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16348-Q&A.jpg)
MO-A-Virtual Acknowledging our Past & Moving IMRT QA Forward: Let's Do This Together Q & A
Q & APresented by
This presentation has an average satisfaction 4.0 (higher is better), with 3 responding
VLID: 16348
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16349-Dieterich.jpg)
MO-C-Virtual Gaps Filled: Advances in IMRT QA Guidance
Guidance for computational and systematic error prevention methodsPresented by Sonja Dieterich, PhD, UC Davis Medical Center
This presentation has an average satisfaction 4.4 (higher is better), with 10 responding
VLID: 16349
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16350-Miften.jpg)
MO-C-Virtual Gaps Filled: Advances in IMRT QA Guidance
Guidance for Measurement-based MethodsPresented by Moyed Miften, PhD, University of Colorado School of Medicine
This presentation has an average satisfaction 4.0 (higher is better), with 6 responding
VLID: 16350
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16351-Q&A.jpg)
MO-C-Virtual Gaps Filled: Advances in IMRT QA Guidance Q & A
Q & APresented by
This presentation has an average satisfaction 4.2 (higher is better), with 9 responding
VLID: 16351
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16352-Molineu.jpg)
MO-E-Virtual Lessons learned from Pre-treatment IMRT QA Failures
Gems from the IROC-Houston Phantom ProgramPresented by Andrea Molineu, MS, UT MD Anderson Cancer Center
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 16352
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16353-Steers.jpg)
MO-E-Virtual Lessons learned from Pre-treatment IMRT QA Failures
The Imperfection of our Analytical Methods for IMRT QAPresented by Jennifer Steers, BSE, UC-San Diego
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 16353
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16354-Q&A.jpg)
MO-E-Virtual Lessons learned from Pre-treatment IMRT QA Failures Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16354
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16355-Halvorsen.jpg)
MO-G-Virtual The Impact on IMRT QA of the Changing Landscape of Resource Utilization
A Holistic Approach Towards Resource UtilizationPresented by Per Halvorsen, MS, Beth Israel - Lahey Health
This presentation has an average satisfaction 4.3 (higher is better), with 4 responding
VLID: 16355
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16356-White.jpg)
MO-G-Virtual The Impact on IMRT QA of the Changing Landscape of Resource Utilization
The impact of current and future IMRT Plan verification methods on reimbursementPresented by Gerald White, MS, Medical Physics Services
This presentation has an average satisfaction 4.5 (higher is better), with 2 responding
VLID: 16356
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16357-Q&A.jpg)
MO-G-Virtual The Impact on IMRT QA of the Changing Landscape of Resource Utilization Q & A
Q & APresented by
This presentation has an average satisfaction 4.5 (higher is better), with 2 responding
VLID: 16357
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16358-Moran.jpg)
MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel MemberPresented by Jean Moran, PhD
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16358
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16359-Dieterich.jpg)
MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel MemberPresented by Sonja Dieterich, PhD, UC Davis Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16359
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16360-Miften.jpg)
MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel MemberPresented by Moyed Miften, PhD, University of Colorado School of Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16360
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16361-Molineu.jpg)
MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel MemberPresented by Andrea Molineu, MS, UT MD Anderson Cancer Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16361
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16362-Steers.jpg)
MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel MemberPresented by Jennifer Steers, BSE, UC-San Diego
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16362
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16363-Halvorsen.jpg)
MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel MemberPresented by Per Halvorsen, MS, Beth Israel - Lahey Health
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16363
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16364-White.jpg)
MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session
Panel MemberPresented by Gerald White, MS, Medical Physics Services
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16364
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16365-Q&A.jpg)
MO-I-Virtual Where are our IMRT QA pain points? Discussion of Day 1 session Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16365
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16374-Smith.jpg)
TU-A-Virtual Risk points in the Process of Care
IMRT QA: What it detects, what it doesn'tPresented by Koren Smith, MS, UMass Chan Medical School/IROC RI
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 16374
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16375-Ford.jpg)
TU-A-Virtual Risk points in the Process of Care
Building a better safety net: Combining QA approaches to maximize safetyPresented by Eric Ford, PhD, University of Washington
This presentation has an average satisfaction 3.7 (higher is better), with 6 responding
VLID: 16375
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16376-Q&A.jpg)
TU-A-Virtual Risk points in the Process of Care Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16376
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16379-Adamson.jpg)
TU-C-Virtual Delivery-based methods - Methodology and gaps
Delivery-based computational and transmission methods for IMRT QAPresented by Justus Adamson, PhD, Duke University Medical Center
This presentation has an average satisfaction 4.3 (higher is better), with 3 responding
VLID: 16379
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16380-Greer.jpg)
TU-C-Virtual Delivery-based methods - Methodology and gaps
Transit Dosimetry for IMRT QAPresented by Peter Greer, PhD, Calvary Mater Newcastle
This presentation has an average satisfaction 4.5 (higher is better), with 2 responding
VLID: 16380
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16381-Q&A.jpg)
TU-C-Virtual Delivery-based methods - Methodology and gaps Q & A
Q & APresented by
This presentation has an average satisfaction 4.5 (higher is better), with 2 responding
VLID: 16381
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16404-Ruan.jpg)
TU-E-Virtual Emerging Computational Methods (AI) - Methodology, gaps, and promises for the future
Opportunities and cautions to advance IMRT QA with AIPresented by Dan Ruan, PhD, UCLA School of Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16404
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16405-Witztum.jpg)
TU-E-Virtual Emerging Computational Methods (AI) - Methodology, gaps, and promises for the future
Finding the right fit for AI in IMRT QAPresented by Alon Witztum, MS, University of California, San Francisco
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16405
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16406-Q&A.jpg)
TU-E-Virtual Emerging Computational Methods (AI) - Methodology, gaps, and promises for the future Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16406
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16386-Perez-Andujar.jpg)
TU-G-Virtual Designing a Comprehensive
Safety Barriers for IMRT Delivery AccuracyPresented by Angelica Perez-Andujar, PhD, Memorial Sloan Kettering
This presentation has an average satisfaction 4.3 (higher is better), with 6 responding
VLID: 16386
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16387-Paradis.jpg)
TU-G-Virtual Designing a Comprehensive
Safety Barriers for IMRT Plan QualityPresented by Kelly Paradis, PhD, Michigan Medicine
This presentation has an average satisfaction 4.2 (higher is better), with 6 responding
VLID: 16387
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16388-Covington.jpg)
TU-G-Virtual Designing a Comprehensive
The Power of Automation for IMRT QAPresented by Elizabeth Covington, PhD, University of Alabama-Birmingham
This presentation has an average satisfaction 4.6 (higher is better), with 5 responding
VLID: 16388
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16389-O-Daniel.jpg)
TU-G-Virtual Designing a Comprehensive
Putting the Pieces together to Increase Patient SafetyPresented by Jennifer O'Daniel, PhD, Duke University Medical Center
This presentation has an average satisfaction 4.4 (higher is better), with 5 responding
VLID: 16389
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16390-Q&A.jpg)
TU-G-Virtual Designing a Comprehensive Q & A
Q & APresented by
This presentation has an average satisfaction 3.3 (higher is better), with 3 responding
VLID: 16390
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16393-Ford.jpg)
TU-I-Virtual The Way Forward - Focus on Day 2
Panel MemberPresented by Eric Ford, PhD, University of Washington
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16393
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16394-Smith.jpg)
TU-I-Virtual The Way Forward - Focus on Day 2
Panel MemberPresented by Koren Smith, MS, UMass Chan Medical School/IROC RI
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16394
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16395-Adamson.jpg)
TU-I-Virtual The Way Forward - Focus on Day 2
Panel MemberPresented by Justus Adamson, PhD, Duke University Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16395
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16396-Greer.jpg)
TU-I-Virtual The Way Forward - Focus on Day 2
Panel MemberPresented by Peter Greer, PhD, Calvary Mater Newcastle
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16396
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16397-Ruan.jpg)
TU-I-Virtual The Way Forward - Focus on Day 2
Panel MemberPresented by Dan Ruan, PhD, UCLA School of Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16397
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16398-Witztum.jpg)
TU-I-Virtual The Way Forward - Focus on Day 2
Panel MemberPresented by Alon Witztum, MS, University of California, San Francisco
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16398
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16399-O'Daniel.jpg)
TU-I-Virtual The Way Forward - Focus on Day 2
Panel MemberPresented by Jennifer O'Daniel, PhD, Duke University Medical Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16399
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16400-Paradis.jpg)
TU-I-Virtual The Way Forward - Focus on Day 2
Panel MemberPresented by Kelly Paradis, PhD, Michigan Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16400
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16401-Covington.jpg)
TU-I-Virtual The Way Forward - Focus on Day 2
Panel MemberPresented by Elizabeth Covington, PhD, University of Alabama-Birmingham
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16401
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16402-Perez-Andujar.jpg)
TU-I-Virtual The Way Forward - Focus on Day 2
Panel MemberPresented by Angelica Perez-Andujar, PhD, Memorial Sloan Kettering
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16402
![](//assets.vl.aapm.org/vl/2022/IMRT/0-16403-Q&A.jpg)
TU-I-Virtual The Way Forward - Focus on Day 2 Q & A
Q & APresented by
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 16403